O

OrbiMed Portfolio holdings

AUM $4.17B
1-Year Est. Return 30.9%
This Quarter Est. Return
1 Year Est. Return
+30.9%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.45B
AUM Growth
+$454M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
130
New
Increased
Reduced
Closed

Top Buys

1
+$54.1M
2
+$47.9M
3
+$40.9M
4
QTTB icon
Q32 Bio
QTTB
+$38.4M
5
ESPR icon
Esperion Therapeutics
ESPR
+$36.7M

Top Sells

1
+$147M
2
+$93.5M
3
+$84.9M
4
SWTX
SpringWorks Therapeutics
SWTX
+$74.4M
5
THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
+$71.7M

Sector Composition

1 Healthcare 99.34%
2 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
126
– –
-45,000
127
– –
-3,122,770
128
– –
-296,000
129
– –
-2,365,213
2 3 4 5
6